Boerhinger funds ADA initiative

Boehringer Ingelheim is sponsoring a collaborative research project with the American Diabetes Association to improve the evidence base for and clinical care of patients with chronic kidney disease and diabetes.

The three-year commitment includes $1.5 million from Boehringer, which will be managed by the ADA.

“Diabetes is the leading cause of kidney failure, accounting for more than 40% of new cases,” the American Diabetes Association's president of medicine and science Elizabeth Seaquist said in a statement.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.